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Abstract
Background: Gene Ontology (GO) is a standard vocabulary of functional terms and allows for
coherent annotation of gene products. These annotations provide a basis for new methods that
compare gene products regarding their molecular function and biological role.
Results: We present a new method for comparing sets of GO terms and for assessing the
functional similarity of gene products. The method relies on two semantic similarity measures;
simRel and funSim. One measure (simRel) is applied in the comparison of the biological processes
found in different groups of organisms. The other measure (funSim) is used to find functionally
related gene products within the same or between different genomes. Results indicate that the
method, in addition to being in good agreement with established sequence similarity approaches,
also provides a means for the identification of functionally related proteins independent of
evolutionary relationships. The method is also applied to estimating functional similarity between
all proteins in Saccharomyces cerevisiae and to visualizing the molecular function space of yeast in
a map of the functional space. A similar approach is used to visualize the functional relationships
between protein families.
Conclusion: The approach enables the comparison of the underlying molecular biology of
different taxonomic groups and provides a new comparative genomics tool identifying functionally
related gene products independent of homology. The proposed map of the functional space
provides a new global view on the functional relationships between gene products or protein
families.
Background
Genome annotation relies heavily on bioinformatics
methods. The identification of homologous relationships
is a powerful and frequently used approach for protein-
level annotation [1], where query protein sequences are
compared to sequences of characterized proteins in order
to find homologies. Based on this comparison, proteins of
unknown function are assigned to characterized protein
families, generating testable hypotheses of their molecu-
lar function. However, this established annotation
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[2,3] suggest that up to 30% of the function annotations
made through sequence similarity searches might be erro-
neous. Obviously, there is no simple relationship between
sequence similarity and function, but some general trends
have been observed. The same authors showed that the
Enzyme Classification (EC) [4] number tends to be com-
pletely conserved only for proteins with more than 80%
sequence identity. They found that it is problematic to
assign EC numbers based on a sequence alignment with
less than 30% identity.
Complementary to sequence similarity searches, more
direct approaches for the functional characterization of
gene products have been proposed. In particular, genomic
context methods predict which gene products are
involved in common biological processes [5,6]. Other
methods use different protein features or structural infor-
mation to predict the function of a gene product [7-9].
The Gene Ontology Consortium provides a structured
standard vocabulary for describing the function of gene
products [10]. The Gene Ontology (GO) is divided into
three orthogonal ontologies, biological process, molecular
function, and cellular component. The three ontologies are
represented as directed acyclic graphs (DAG) in which
nodes correspond to terms and their relationships are rep-
resented by edges. Each node can have several parents and
several children. There are two types of relationships. "is-
a" indicates that the child is a subclass of the parent, and
"part-of" is used when the child is a component of the par-
ent. GO terms are widely used to annotate genes and their
products with functional terms [11].
New methods can exploit these GO annotations in order
to compare gene products on the basis of their function.
There are some issues which one has to take into account
when GO annotations are compared. One problem is that
the depth of a term in the GO graph is not representative
of the specificity of the underlying concept. Different
terms on the same rank (same depth in the GO graph)
usually are not equally specific. In addition, GO is an
ongoing project in which new terms are added continu-
ously but many specific functional terms may still be
missing. The manual mapping of GO terms to genes is
based on results available in the scientific literature or in
public databases, but relies on human decision and there-
fore is considerably subjective [12]. In addition, a large
part of gene products is not yet annotated with GO terms.
These problems have to be considered when designing
robust measures to assess the similarity of two GO terms.
Semantic similarity measures have been proposed for
comparing concepts within an ontology. Resnik [13,14]
developed a measure of semantic similarity for "is-a"
ontologies based on the information content of the lowest
common ancestor (LCA) of two terms. The more fre-
quently a term occurs, i.e., the higher its probability of
occurring, the lower its information content. If the LCA of
two terms describes a generic concept, these terms are not
very similar and this is reflected in a low information con-
tent of their LCA. This measure considers how specific the
LCA of the two terms is but disregards how far away the
two terms are from their LCA. Lin [15] developed a related
measure that depends on the information content of the
LCA and of the two terms that are compared. This measure
assesses how close the terms are to their LCA. It does not
refect the level of detail of the lowest common ancestor,
though.
Protein sequences annotated with GO terms can be com-
pared on the basis of such semantic similarity measures.
Lord et al. [16] were the first to apply a measure of seman-
tic similarity to GO annotations. They implemented
GOGraph, a tool for calculating the semantic similarity of
protein pairs based on Resnik's measure. The semantic
similarity between two proteins is defined as the average
similarity of all GO terms with which these proteins are
annotated. Each protein pair receives three similarity val-
ues, one for each ontology. Cao et al. [17] integrated a
semantic similarity search into the Bio-Data Warehouse.
They use also Resnik's measure to define the similarity
between two single GO terms. Speer et al. [18] employed
a distance measure based on Lin's similarity for clustering
genes on a microarray according to their function. Khatri
and Draghici reviewed tools for ontological analysis of
gene expression data [19]. Friedberg and Godzik [20] used
the molecular function annotation of protein structures in
the Protein Data Bank (PDB) [21] to perform a functional
comparison of different folds. They define a GO-based
fold similarity as the normalized average Resnik term sim-
ilarity of two folds. Lee and Lee [22] applied Resnik's
semantic similarity measure to MIPS [23] and GO anno-
tations in order to infer modularized gene networks. They
divide the GO annotations into three sets, set 1 contains
all GO terms annotated to both genes, set 2 and set 3 con-
tain the GO terms annotated to only one of them. Then
the maximum similarity between any terms from set 2
and terms from set 3 is calculated (max2, 3). Finally, the
annotation information score is the sum of all self-simi-
larities of terms in set 1 plus max2, 3. Shalgi et al. utilized
Lord's definition for a subcellular clustering score based
on the cellular component ontology. They calculate the
similarity of two genes as the maximum similarity of GO
terms annotated to one of the genes. Björklund et al. [24]
developed a domain distance score for assessing the simi-
larity of two domain architectures. They showed that the
domain distance correlates well with Lord's approach to
semantic similarity of proteins. Sevilla et al. [25] analyzed
the correlation between gene expression and Resnik's andPage 2 of 16
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Resnik's measure correlates well with gene expression.
Gene products are functionally similar if they have com-
parable molecular functions and are involved in similar
biological processes. These gene products did not neces-
sarily evolve from a common ancestor and therefore do
not necessarily show sequence similarity. GO annotations
capture the available functional information of a gene
product and can be used as a basis for defining a measure
of functional similarity between gene products. In this
paper, we introduce a new measure of similarity between
GO terms that is based on Lin's and Resnik's definitions.
The measure simRel takes into account how close terms are
to their LCA as well as how detailed the LCA is, i.e., distin-
guishes between generic and specific terms. This simRel
score is the basis for a new measure, called funSim, for
assessing the functional relationship between two gene
products. funSim extends the measure of similarity to the
comparison of two functional annotations, each com-
posed of sets of GO terms from different ontologies. The
funSim score allows for identifying functionally related
gene products from different species that have no signifi-
cant sequence similarity. The measure also allows for par-
tial matches, resulting in a more robust similarity score for
the comparison of gene products with incomplete anno-
tation or for the comparison of multi-functional proteins.
We used simRel to identify all biological processes from
fungi that do not appear in mammals. Furthermore, simRel
was used to find molecular functions from Mycobacteria
that do not appear in mammals. We compared the funSim
score to established sequence similarity approaches. The
method was also applied to find the proteins from human
that are functionally related to yeast proteins. We com-
pared the yeast proteins with each other using funSim, and
obtained a functional map using multidimensional scal-
ing. We also applied funSim to the functional comparison
of all Pfam families and generated a functional map of the
protein families.
Results and discussion
Comparing biological processes and molecular functions
The simRel measure was used to investigate the similarities
and differences of the molecular biology between differ-
ent taxonomic groups. The simRel score ranges between 0
and 1. GO terms with a simRel score above 0.9 correspond
to highly similar functions. Between 0.5 and 0.7, the two
GO terms may be considered functionally related and
below 0.3, they are not functionally similar. The relation-
ship between simRel score and functional similarity is illus-
trated with some examples. Comparing the GO term
"biotin biosynthesis" (GO:0009102) with itself results in
a simRel score of 0.99993. The score is smaller than 1.0
because simRel relies on the probability of the term (see
Methods for details). The terms "ATP-dependent chroma-
tin remodeling" (GO:0043044) and "chromatin silencing
at telomere" (GO:0006348) have a similarity score of
0.75098. These two terms are both descendants of "chro-
matin remodelling" (GO:0006338) and represent related
biological processes. The biological process "aromatic
amino acid transport" (GO:0015801) and "L-glutamate
transport" (GO:0015813) have a score of 0.55565. The
lowest common ancestor of the two terms, "amino acid
transport" (GO:0006865), is rather generic, resulting a
low simRel score. The process "chitin localization"
(GO:0006033) and the unrelated process "ATP synthesis
coupled proton transport" (GO:0015986) have a low sim-
ilarity score (0.30027).
The simRel measure was used to find processes from fungi
that are not present in mammals. This kind of investiga-
tion is of medical interest, as proteins involved in biolog-
ical processes unique to pathogens and absent in the host
are potential drug targets. The fifty most dissimilar biolog-
ical processes from fungi and mammals are provided in
the supplementary material (see Additional file 1, Table
S1). "Plasmid partitioning" (GO:0030541) and "chitin
localization" (GO:0006033) have the lowest simRel scores,
0.15808 and 0.30027 respectively. They are unique to
fungi, in particular "chitin localization" is a promising
candidate for finding new drug targets [26]. The next step
should be to assess the relevance of the individual pro-
teins associated with the selected processes for the survival
of the organism. Both "Boron transport" (GO:0046713)
and "snoRNA transcription" (GO:0009302) have a low
score, which reveals how the comparison results depend
on the quality of the functional annotations. The human
protein with the UniProt accession Q8NBS3 is actually
involved in "boron transport" [27] but this is not yet
annotated with GO terms in UniProt. One yeast protein
(UniProt accession: P53538) is annotated with "snoRNA
transcription" [28]. There is a predicted human ortholo-
gous gene in Ensembl (ENSG00000160075) that belongs
to the same InterPro family [29] (IPR006811) as the yeast
protein, but the human gene product is also not yet anno-
tated with GO.
Additionally, the simRel score was used to find molecular
functions from the genus Mycobacterium that cannot be
found in mammals. Our database contains annotations
for proteins of several Mycobacterium pathogens. M. avium
paratuberculosis is the causative agent for Johne's disease in
ruminants and it is possibly linked to Crohn's disease in
humans. M. bovis causes tuberculosis in most animals and
in cattle in particular. M. tuberculosis and M. leprae cause
tuberculosis and leprosy in humans, respectively. A list of
the 60 most dissimilar functions according to simRel is
given in the Supplement (see Additional file 1, Table S2).
The molecular function with the lowest simRel score
(0.05293) corresponds to "3,4-dihydroxy-2-butanone-4-Page 3 of 16
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molecular function in Mycobacteria that is absent in mam-
mals. In fact, this catalytic activity corresponds to one of
the first steps in riboflavin biosynthesis. Riboflavin is the
precursor of flavocoenzymes which are essential for the
catalysis of a variety of redox-reactions. Riboflavin is pro-
duced in microorganisms, fungi, and plants but is an
essential nutrient for animals. The riboflavin biosynthetic
pathway has been considered a potential drug target for
anti-infectives against pathogenic fungi, bacteria, and
mycobacteria in particular [30,31]. There has also been
some specific interest on developing inhibitors of the 3,4-
dihydroxy-2-butanone-4-phosphate synthase from differ-
ent fungi [32,33] but so far there has been no specific
study on mycobacteria. Other molecular functions not
found in mammals of interest for drug discovery can be
found in the list. For example, "UDP-N-acetylmuramate
dehydrogenase activity" (GO:0008762), simRel = 0.59661,
is one step in the synthesis of bacterial peptidoglycan, or
"adenosylmethionine-8-amino-7-oxononanoate
transaminase activity" (GO:0004015), simRel = 0.6486,
which is part of the biotin synthesis.
Comparison of funSim and sequence similarity
The funSim score ranges from 0 to 1, which translates into
an increasing degree of functional similarity, in a compa-
rable way to the simRel score. This is expected as the funSim
score is a combination of simRel scores. A funSim score
close to one indicates high functional similarity whereas a
score close to zero indicates low similarity. We analyzed
the distribution of the funSim score and its two compo-
nents, the MFscore (for molecular function) and the
BPscore (for biological process), in four different catego-
ries of protein pairs corresponding to four levels of evolu-
tionary relationship: no sequence similarity (NSS), low
sequence similarity (LSS), high sequence similarity (HSS),
and orthology according to Inparanoid (IO) [34]. GO
annotation with IEA (inferred from electronic annota-
tion) and ISS (inferred from sequence or structural simi-
larity) evidence codes was disregarded. Figures 1A and 1B
show the distribution of the MFscore and the BPscore in the
four datasets. Almost 60% of the protein pairs in the IO
dataset have an MFscore above 0.8 and 45% have a BPscore
in the same range. This indicates that Inparanoid ortholog
proteins tend to have similar molecular functions and are
also involved in similar biological processes, although to
a smaller extent. Some protein pairs in the IO set have
scores below 0.2, indicating no functional similarity. It
can be seen in all four datasets (NSS, LSS, HSS, IO), that
there are more protein pairs with an intermediate BPscore
between 0.2 and 0.8 than with a MFscore in the same
range. This is caused by the lower density of the molecular
function ontology. High-level terms in this ontology are
less connected than high-level terms in the biological
process ontology which results in lower scores for molec-
Distribution of the MFscore (A), BPscore (B), funSim score (C) for different sets of protein pairs excluding IEA and ISS anno-tationFigure 1
Distribution of the MFscore (A), BPscore (B), funSim 
score (C) for different sets of protein pairs excluding 
IEA and ISS annotation. The bins correspond to the fol-
lowing intervals of funSim values: S0.0: [0.0, 0.2[; S0.2: [0.2, 
0.4[; S0.4: [0.4, 0.6[; S0.6: [0.6, 0.8[; S0.8: [0.8, 1.0]. The per-
centage values are calculated according to the total number 
of protein pairs in the different categories. The sets of the 
different categories contain the following numbers of protein 
pairs: NSS 288, LSS 364, HSS 338, and IO 563. The distribu-
tions were calculated by excluding all proteins with GO 
annotations with the evidence code IEA (inferred from elec-
tronic annotation) and ISS (inferred from sequence or struc-
tural similarity) from the datasets.Page 4 of 16
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tional similarity (S0.8) is highest for the IO category, and
decreases for HSS and LSS, to almost no protein pairs
without sequence similarity (NSS). The reverse order is
observed for the proteins without functional similarity
(S0.0) where the highest percentage is observed for NSS
and then in decreasing order LSS, HSS, and IO. This effect
is more pronounced for the MFscore than for the BPscore.
Figure 1C shows the distribution of the funSim score for
the different datasets. Since the funSim score is based on
the other two scores, it has an intermediate distribution.
About half of the orthologous protein pairs have a score
above 0.6 indicating some functional relationship
between the proteins. In particular the highest peak is at
S0.8 which indicates high functional relatedness of the
proteins. Nevertheless, 25% of the orthologous protein
pairs have a funSim value below 0.4 indicating a very low
functional similarity. The IO distribution shows a local
peak at S0.4 which is a result of the combination of the
MFscore and the BPscore for funSim. A considerable
number of protein pairs have a high MFscore and a low
BPscore or vice versa, resulting in funSim scores in the
range between 0.4 and 0.6, as explained later in Figure 2.
The protein pairs in the set NSS have very low scores with
few exceptions. This indicates that there is almost no func-
tional relationship between random pairs. The distribu-
tions for the LSS and the HSS sets show considerable
similarity. However, there is shift in the LSS distribution
towards lower scores if compared to the HSS distribution.
Figure S1 (see Additional file 1) shows the same type of
results as Figure 1 but including all available annotation.
There is no considerable difference between the distribu-
tions in Figure 1 and Figure S1 (see Additional file 1). The
only exception is the distribution of LSS and HSS protein
pairs which have a higher percentage of high BPscores
(S0.8). This is also refected by the funSim score, though to
a lower extend. In general, excluding the electronic anno-
tations does not have a great effect on the distribution of
the similarity scores.
Figure 2 shows a histogram of the relationship between
MFscore and BPscore for the proteins in the IO dataset. The
bars are colored according to the funSim score of the pro-
tein pairs. The highest peak occurs at M0.9 and B0.9,
which indicates that many Inparanoid orthologous pairs
perform the same function and are involved in the same
processes. A considerable number of protein pairs have a
Distribution of MFscore and BPscore values for the IO datasetFigure 2
Distribution of MFscore and BPscore values for the IO dataset. The bins correspond to the same intervals as in Figure 
1. The bars are colored according to the funSim score of the protein pairs contained.Page 5 of 16
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a low score (lower than 0.2) in the other ontology. This
corresponds to the upper left and the lower right corners
of the plot. These proteins have either similar molecular
function but take part in different biological processes or
belong to similar biological processes and perform differ-
ent molecular functions. These proteins have a funSim
score between 0.4 and 0.6, resulting in the local peak for
ortholog proteins at S0.4 in Figure 1C.
We compared our measure of functional similarity
between gene products to the approach previously pro-
posed by Lord et al. [16]. In performing this comparison,
we were faced with several challenges; the lack of objective
validation sets, the fact that Lord's measure can be arbi-
trarily large, and the fact that there is no established cutoff
for significant similarity for functional similarity meas-
ures. However, a partial comparison of the two
approaches is still possible regarding the combination of
semantic similarity scores. We compared the proposed
MFscore and BPscore to the corresponding MFscoreLord and
BPscoreLord, which rely on the average semantic similarity
between the GO terms as proposed by Lord (see Meth-
ods). In order to obtain scores that range within prede-
fined intervals with Lord's measure, we used simRel to
estimate the semantic similarity between GO terms. We
calculated MFscoreLord and BPscoreLorddistributions for the
NSS, LSS, HSS, and IO sets. It is expected that most protein
pairs in the NSS set are not functionally related and there-
fore should obtain low GOscores whereas pairs in the IO
set generally have similar functions. However, the NSS set
also contains functionally related proteins that share no
significant sequence similarity. Although this prevents an
objective performance assessment, the comparison of the
shapes of the distributions of the GOscores for the NSS and
the IO sets provides an indication of the discriminative
power of the two approaches. We observe that the shapes
of the distributions of MFscoreLord and BPscoreLord (Figure
3) differ from that of the corresponding distributions of
MFscore and BPscore (Figure 1). There is a substantially
lower percentage of protein pairs with MFscoreLord above
0.8 than with MFscore but a higher percentage of pairs
with similarity between 0.2 and 0.6. The MFscoreLord distri-
bution of the IO set has two peaks, one at S0.4 and one at
S0.8. Therefore, MFscoreLord does not discriminate as
clearly between non-homologous and homologous, and
in particular orthologous, proteins as MFscore does. The
NSS results for MFscoreLord closely resemble the results
with MFscore. In case of the BPscoreLord, the IO, HSS, and
LSS distributions are more uniform without pronounced
peaks compared to the BPscore. The NSS distribution is
again very similar to the distribution obtained with
BPscore. We performed a χ2-test to investigate whether the
distributions obtained by MFscore and BPscore differ sig-
nificantly from the distributions generated by MFscoreLord
and BPscoreLord, respectively. Except for the NSS distribu-
tions, the χ2-test supports this expectation with p-values
less than 10-4.
In summary, these results confirm that functionally
related proteins tend to have higher sequence similarity.
This is more evident for the MFscore. Nevertheless, a con-
siderable percentage of protein pairs that are orthologous
and that have a high sequence similarity show no func-
tional similarity. The comparison with Lord's approach to
combine semantic similarity scores shows significantly
different results. In particular, the proposed approach is
expected to provide a better discrimination between non-
homologous and orthologous proteins.
Distribution of the MFscoreLord (A) and BPscoreLord (B) for dif-ferent sets of protein pairs excluding IEA and ISS annotationFigure 3
Distribution of the MFscoreLord (A) and BPscoreLord (B) 
for different sets of protein pairs excluding IEA and 
ISS annotation. The bins correspond to the same intervals 
as in Figure 1. The percentage values are calculated according 
to the total number of protein pairs in the different catego-
ries. The sets of the different categories contain the following 
numbers of protein pairs: NSS 288, LSS 364, HSS 338, and IO 
563. The distributions were calculated by excluding all pro-
teins with GO annotations with the evidence code IEA 
(inferred from electronic annotation) and ISS (inferred from 
sequence or structural similarity) from the datasets.Page 6 of 16
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For each yeast protein, the funSim score was used to search
for the functionally related proteins in human. As a result
of this directional comparison, each yeast protein is
mapped to a list of functionally related human proteins
sorted by funSim. In total, we compared the 7 356 yeast
proteins from UniProt to the 70447 proteins from human
in UniProt. Figure 4 shows the overall distribution of the
highest funSim score for each yeast protein. The distribu-
tion shows that there are only about 30 yeast proteins
with a score below 0.4, which indicates that there is no
functionally related protein in human. For almost 2 200
(30%) yeast proteins, there is a functionally very similar
protein in human with a score above 0.8. Out of these
protein pairs with funSim score above 0.8, more than 1
600 have no significant sequence similarity with human
proteins (NoSeqSim) and almost 1 400 share no Pfam
[35] families with human proteins. These functionally
related protein pairs are either non-homologous and
evolved independently to a similar function or are remote
homologs that cannot be identified by standard sequence-
based methods.
We further analyzed some of the yeast-human protein
pairs associated with different ranges of funSim values.
The Glutaredoxin-1 from yeast (UniProt accession:
P25373) matches two proteins from human (UniProt
accessions: Q6NXQ3, Q5T501) with a very high funSim
score (0.99968). All these three proteins have glutathione
peroxidase activity as response to oxidative stress. Accord-
ing to both SCOP [36] and Pfam, the human proteins are
classified in the same family, but the yeast protein belongs
to a different family. All three proteins are in the same
SCOP superfamily (thioredoxin-like), although there is
no significant sequence similarity between the human
proteins and the yeast protein.
The phosphoacetylglucosamine mutase from yeast (Uni-
Prot accession: P38628) matches one human protein with
a considerable funSim score of 0.843. This human protein
is also a phosphoacetylglucosamine mutase (UniProt
accession: O95394) and performs exactly the same func-
tion on the same pathway, but the human protein is
annotated to a more generic biological process GO term.
The two proteins are reported as orthologs by Inparanoid
[34]. They have a sequence identity of almost 46% and
share two Pfam families. These two proteins are function-
ally very similar.
Decarboxylating sterol-4-alpha-carboxylate 3-dehydroge-
nase (UniProt accession: P53199) from yeast is annotated
with the molecular function "C-3 sterol dehydrogenase
(C-4 sterol decarboxylase) activity" (GO:0000252) and
with "ergosterol biosynthesis" (GO:0006696) biological
process. The functionally most similar human protein is
the sigma 1 isoform 1 variant Opioid receptor (UniProt
accessions: Q53GN2, Q5T1J1) with a funSim score of
0.5005. It is annotated to the molecular function "C-8
sterol isomerase activity" (GO:0000247) and is involved
in the same process as the yeast protein. The two proteins
perform different functions but take part in the same proc-
esses, which translates into a low MFscore (0.0303) and a
high BPscore (1.0).
The serine/threonine-protein kinase ATG1 (UniProt
accession: P53104) from yeast is involved in the
"autophagy" (GO:0006914) process. The human protein
with the highest funSim score (0.507) is phosphorylase b
kinase gamma catalytic chain (UniProt accession:
P15735), also with serine/threonine protein kinase
molecular function according to the GO annotation.
However, the human protein is involved in the "glycogen
metabolism" (GO:0005977) process. Both proteins share
the protein kinase domain from Pfam (Pfam accession:
PF00069) and have a sequence similarity of 27%. The pro-
teins have the same molecular function (MFscore 0.994),
but take part in different processes (BPscore 0.159), the
type of functional relationship that tends to be predicted
by homology-based methods.
The best hit for the nicotinamide riboside kinase 1 from
yeast (UniProt accession: P53915) is the UMP-CMP
kinase (UniProt accession: P30085) with a funSim =
0.303. The yeast protein catalyzes the synthesis of nicoti-
namide nucleotide from nicotinamide riboside, whereas
the human protein catalyzes phosphoryl transfer from
Functional comparison of yeast proteins with human proteinsigure 4
Functional comparison of yeast proteins with human 
proteins. Only the best hit (highest funSim score) for each 
yeast protein was taken into account for the score distribu-
tion. For the NoSeqSim bin, a BLAST comparison was per-
formed with default parameters for the proteins with funSim 
above 0.8 (in bin S0.8), and the pairs with no significant 
sequence similarity (e-value > 10-3) were considered.Page 7 of 16
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which is reflected in the low score.
Yeast-yeast comparison
Based on the MFscore, the dmf score was defined as a meas-
ure for functional distance with regard to the molecular
function (see Methods section). This score is calculated as
dmf = 1 - MFscore. We computed dmf scores for all pairwise
combinations of yeast proteins. The underlying dataset
consists of all yeast proteins from UniProt with molecular
function annotation, 3 459 proteins in total, resulting in
5980611 unique protein pairs. Approximately 5.3 million
pairwise distances were larger than 0.8, indicating no
functional similarity. Slightly more than 104 000 protein
pairs had a distance below 0.2, suggesting high functional
similarity. The dmf scores have been used as input for met-
ric multidimensional scaling (MDS) and clustering in
order to group the proteins according to their function.
Previously, proteins have been grouped according to
sequence or structure in a similar way [37-39]. Generally,
the goal of MDS is to represent points from a high dimen-
sional space in a lower dimensional space while preserv-
ing the pairwise distances of the term. Normalized stress
is a measure of how well the pairwise distances are pre-
served in the lower dimensional space. Figure 5 shows the
plot with the normalized stress (NS) and the change rate
of normalized stress (CR). NS is a measure of how well the
original distances are represented in the dataset with
reduced dimensionality. The highest CR indicates the
optimal number of dimensions to represent the original
dataset. The normalized stress for the two-dimensional
(2D) MDS of the dataset is 0.45, and the plot indicates
that there is not much improvement in NS by using three
dimensions instead of using two dimensions. The 2D
MDS of the dataset corresponds to the map of the yeast
functional space, and is shown in Figure 6A. The contour
plot in Figure 6B shows the regions corresponding to dif-
ferent functions. Different colors were chosen to match
certain high-level terms that are children of
"molecular_function" and for some combinations of
these high-level terms. Proteins annotated with "catalytic
activity" (1) are arranged along lines in the lower right
part of the plot. Proteins with "binding" (2) annotation
are located on an axis, approximately parallel to the x-axis
to the left of the origin. Proteins annotated with both of
these classes (6) are placed between these two clusters. In
general, proteins with the same function form clusters
along axes and proteins annotated with two different
functions are placed between the corresponding clusters.
Overall, the yeast proteins with different types of molecu-
lar functions are well separated in the MDS plot.
Yeast functional mapFigure 6
Yeast functional map. A: The yeast functional map, 
obtained by 2D-Multidimensional scaling of an all-against-all 
comparison of yeast proteins using dmf. The proteins are rep-
resented by numbers in the plot and are colored according 
to their type of molecular function. The plot shows that the 
proteins group into clusters according to their different func-
tions. Additionally, proteins annotated with two terms are 
placed between the clusters that correspond to the single 
functions. B: Contour plot of the MDS.
Scree-plot of multidimensional scalingFigure 5
Scree-plot of multidimensional scaling. The change rate 
indicates that a five-dimensional space would be optimal for 
representing the data. Furthermore, it indicates that using a 
three dimensional representation does not improve much 
over a two dimensional representation.Page 8 of 16
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nates between proteins with different types of "catalytic
activity". Different colors were chosen to match a subset
of children of "catalytic activity" (Figure 7). It becomes
evident that different regions correspond to different
functional subtypes. The arrangement of common func-
tional subtypes was analyzed in further detail by selecting
six proteins annotated with a molecular function term
descendant of "hydrolase activity" (Figure 8). In general,
the probability of occurrence of the annotated term rises
from the center to the edges of the plot. This means that
proteins located farther away from the origin are anno-
tated with more generic and therefore less relevant GO
terms. The same analysis with the BPscore showed no clear
separation of the different processes. This is possibly due
to the increased density (connectivity) of the biological
process ontology in comparison to the molecular function
ontology.
The same distance matrix was used to perform a hierarchi-
cal clustering of all yeast proteins according to their
molecular function annotation. Figure 9 shows the result-
ing dendrogram. The colors were chosen to match the cat-
egories in the MDS plot (see Figure 6A). It can be seen that
the five high-level functions form distinct clusters. The
largest cluster "catalytic activity" is plotted in red. This
cluster also contains proteins annotated with additional
terms (labels 6 and 8 in Figure 6A). Proteins annotated
with two different functional classes are placed into either
one of the corresponding clusters. Generally, clustering
with dmf separates the yeast proteins according to their
function, but the separation is not as clear as with multi-
dimensional scaling.
Applying funSim to Pfam families
Protein families can also be compared with the funSim
measure, since most Pfam families are also annotated
with GO terms. A funSim comparison based on Pfam fam-
ilies is actually preferred for the genomes for which the
coverage of the GO annotation of the gene products is
rather low, but with a rather high Pfam annotation cover-
age. In general for the completely sequenced genomes, the
Pfam coverage is higher than the GO coverage (Figure 10).
One drawback of the family-based functional comparison
is that the Pfam families are generally annotated with
more generic terms than gene products, because the func-
tional annotation of a family has to fit all its member pro-
teins. The higher the probability of a GO term, the more
generic it is. Comparing the probabilities of GO annota-
tions of human proteins and the probabilities of GO
annotation of human protein families, it is clear that the
Pfam annotation is more generic than the annotation of
the gene products (Figure 11). However, this is not always
the case. Some genomes have been annotated mostly
Detailed analysis of "hydrolase activity"Figur  8
Detailed analysis of "hydrolase activity". Proteins anno-
tated with a descendant of "hydrolase activity" are shown in 
yellow. The six marked proteins (A to F) are all annotated 
with a single molecular function. The proteins are annotated 
with the GO terms as follows: Protein A (YBR177C), "serine 
hydrolase activity" (p = 5.277 * 10-6); Protein B (DBP7), 
"ATP-dependent RNA helicase activity" (p = 4.22 * 10-5); 
Protein C (YAL048C), "GTPase activity" (p = 8.69 * 10-4); 
Protein D (Q36760), "endonuclease activity" (p = 8.96 * 10-
3); Protein E (YDL100C), "ATPase activity" (p = 2.24 * 10-2); 
Protein F (IAH1), "hydrolase activity, acting on ester bonds" 
(p = 2.71 * 10-2). The probability of the annotated term to 
occur increases moving on the line from A to F. This shows 
that proteins annotated with more general terms have a 
larger distance to all other proteins and thus are placed 
towards the edges of the plot.
2D-Multidimensional scaling plot colored according to the type of "catalytic activity" of the pr teinsFigure 7
2D-Multidimensional scaling plot colored according 
to the type of "catalytic activity" of the proteins. Pro-
teins annotated with a descendant are colored according to 
the type of their catalytic activity. One elongated region cor-
responds to "transferase activity" (1), another to "hydrolase 
activity" (2), and another region to "oxidoreductase activity" 
(3). Proteins annotated with "lyase activity", "ligase activity", 
or "isomerase activity" (4) are mostly located along the top 
of the whole "catalytic activity" region.Page 9 of 16
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ity, including Pfam searches with Hidden Markov Models.
In such cases, the gene product annotation will corre-
spond to the functions shared by the different family
members and therefore will match more closely the Pfam
annotation.
Using the dmf score, we calculated all possible pairwise
functional differences for all Pfam families with molecu-
lar function annotation. The resulting distance matrix was
used to perform a 2D MDS, in order to obtain a map of
the Pfam functional space. Figure 12 shows the graphical
representation of the 2D MDS. The protein families are
colored according to their molecular function annotation.
It can be seen that Pfams with the same function form
rather well defined clusters. Overlapping clusters always
contain families that are annotated with one common
and possibly one additional function. Protein families in
some clusters are arranged along axes where families
annotated to more general GO terms locate towards the
edges of the plot. Regions of constant density are shown
as contour lines in the plot. They reveal a quite substantial
overlap of the clusters 2 and 9 which both contain Pfams
annotated to "binding". Additionally, cluster 2 is split
into two distinct regions that are quite large. An analysis
of the two cluster parts shows that the upper part contains
Pfams annotated to "protein binding" (GO:0005515) and
the lower part contains Pfams annotated with other kinds
of "binding". Figure 13 shows the different axes of the
main clusters in the map of the Pfam functional space.
Conclusion
As a result of the genome annotation process, an increas-
ing amount of functional information is being accumu-
lated in a systematic and machine-readable fashion. This
affords a computational approach to comparing gene
Distribution of probability values for GO terms annotated to human pr teins or human PfamFigure 11
Distribution of probability values for GO terms anno-
tated to human proteins or human Pfams. The bins 
correspond to the following intervals of GO term probabil-
ity: P1: [0.0, 10-7[; P2: [10-7, 10-6[; P3: [10-6, 10-5[; P4: [10-5, 
10-4[; P5: [10-4, 10-3[; P6: [10-3, 10-2[; P7: [10-2, 10-1[.
Hierarchical clustering of all yeast proteins using distance based on the MFscoreFigure 9
Hierarchical clustering of all yeast proteins using distance based on the MFscore. The color bar below the dendog-
ram uses the same color scheme as Figure 6A to indicate the molecular function annotation of the proteins. The dendogram 
closely resembles the MDS of the yeast proteins. Five clusters can be seen in the dendogram: "catalytic activity" in red, "bind-
ing" in pink, "transcription regulator activity" in light green, "structural molecule activity" in orange, and "transporter activity" in 
dark blue. The dendogram was produced with the JavaTreeView software http://jtreeview.sourceforge.net/.
Distribution of the GO coverage and Pfam coverageFigure 10
Distribution of the GO coverage and Pfam coverage. 
Distribution of the GO coverage and Pfam coverage from 
UniProt proteins of completely sequenced genomes. GO 
coverage means proteins annotated with molecular function 
and biological process and disregarding cellular component. 
The mean GO coverage for species in the database is 32%. 
The Pfam annotation is more complete with a mean of 67%. 
The bins correspond to the following intervals of coverage: 
B0.0: [0.0, 0.1[; B0.1: [0.1, 0.2[; B0.2: [0.2, 0.3[; B0.3: [0.3, 
0.4[; B0.4: [0.4, 0.5[; B0.5: [0.5, 0.6[; B0.6: [0.6, 0.7[; B0.7: 
[0.7, 0.8[; B0.8: [0.8, 0.9[; B0.9: [0.9, 1.0].Page 10 of 16
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strategy bears the promise of a more direct functional
comparison than traditional sequence comparison meth-
ods. The new approach is not intended to be a replace-
ment of the sequence comparison or homology-based
approaches but rather provides an additional alternative
for the objective comparison of the annotated gene prod-
ucts. Here we propose two new measures for the compar-
ison and identification of functionally related gene
products. The simRel score provides a similarity measure of
two GO terms. It combines the power of Resnik's and
Lin's measures in the sense that both the relevance of the
LCA and the distance to the LCA are taken into account.
The funSim score is based on simRel and compares the GO
annotation of two gene products. The score compares sets
of GO terms from different ontologies, and it allows for
partial matches. Additionally, the dmf score is based on the
MFscore and is used to measure functional distances. Sim-
ilar distance measures can be definied for the simRel score,
the BPscore, and the funSim score.
The MFscore, BPscore, and the funSim score allow for par-
tial matches, therefore they are suitable for the compari-
son of multi-functional gene products. In addition, these
measures are also suitable for the comparison of gene
products for which only part of the functional annotation
is available as GO terms. This can be illustrated by the pre-
vious comparison of Glutaredoxin-1 from yeast (P25373)
and the GPX3 protein from human (Q6NXQ3). The yeast
and human proteins share a peroxidase activity, but the
yeast protein is also annotated as a transferase. The pro-
teins clearly share similar function, which is refected by
the high funSim score (0.99968), although the yeast pro-
tein is annotated with additional functions. Nevertheless,
such sequence-independent similarity measures are
always limited by the availability and quality of the func-
tional annotations and their underlying ontologies. This
is refected by the previously mentioned missing "boron
transport" annotation for the human protein Q8NBS3,
making it impossible to find functionally related proteins
in yeast.
Other measures have been proposed for functional com-
parison of gene products (see Introduction). They are
based either on Resnik's or Lin's similarity measures.
Therefore, they do not consider both the distance to the
LCA and the relevance of the LCA. In addition, these
measures do not explicitly take into account partial
matches, as they penalize all mismatches or consider only
the best single match. The comparison of our measures
with Lord's approach [16] is limited by the lack of a gold
standard for either true positives or true negatives. There-
fore, one is restricted to the comparison of the shapes of
the distributions of scores. If Lord's approach to combin-
ing semantic similarity scores is used, the results differ sig-
nificantly from the ones obtained with the current
approach. The latter approach provides a better discrimi-
nation between non-homologous and homologous, par-
ticularly orthologous proteins. Future progress in this area
requires an objective criterion for testing the performance
of the different measures of functional similarity.
There are several general application scenarios for the pro-
posed measures. The simRel score is used to compare two
sets of GO terms in order to find functional terms that are
common to both sets and unique to each set, respectively.
This is especially valuable for the comparison of the
underlying molecular biology of different groups of
organisms along the taxonomic tree. The comparison of
the biological processes from fungi and mammals given
in the Results section is one such example. Additionally,
the simRel score could be applied in the characterization of
Axes on the Pfam functional mapFigure 13
Axes on the Pfam functional map. The main axes of the 
main clusters from Figure 12 are shown.
Functional map of the Pfam familiesigure 12
Functional map of the Pfam families. Plot of the two-
dimensional multidimensional scaling of the Pfam families. 
The colors were chosen to resemble the molecular function 
annotation.Page 11 of 16
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ferent environments [40]. In the second application sce-
nario gene products are compared using the funSim score
in order to find functional relationships. All gene prod-
ucts from a single genome are compared and grouped
according to function. An example is the multidimen-
sional scaling and the cluster analysis of the yeast proteins
(see Figures 6A, 9). A similar analysis can be performed on
protein families in order to generate a map of the family
functional space. Alternatively, two genomes are com-
pared to find functionally similar gene products and to
identify gene products unique to one of the species,
respectively, as in the comparison between yeast and
human proteins (see Figure 4). To summarize, the
approach enables the comparison of the molecular func-
tions and biological processes found in different groups of
organisms and provides a new tool to identify function-
ally related gene products independent of homology.
One can foresee applications that are not only biologically
but also medically relevant. In particular, these compari-
sons can provide better understanding of pathogenicity
and aid in the identification of new drug targets. For
example, established comparative genomics approaches
for drug target discovery are based on sequence similarity
searches [41,42], and can be extended to include semantic
similarity searches for functional comparison.
Although this approach is promising, the quality of the
results is still quite sensitive to the quality of the annota-
tions. However, there is reason to be optimistic, since the
situation is expected to improve as new GO terms are
added and as more genes are annotated. The "is-a" and
"part-of" relationships between GO terms are not distin-
guished in the current approach. This problem should be
addressed in the future. Another possible extension is to
include cellular component into the funSim score in order
to completely assess the function and the cellular location
of a gene product.
A future goal is to identify functionally equivalent gene
products from different genomes. They perform the same
molecular functions, take part in the same biological
processes and are located in the same cellular component.
The definition of functional equivalence is more generic
than that of orthology as it does not depend on hom-
ology. The funSim score can be used as a basis for defining
a new measure to identify the functionally equivalent
gene products from different species.
Methods
Database
A database (GOTaxDB) was implemented that integrates
information from different sources. The database contains
the NCBI Taxonomy [43] downloaded on August 22nd,
2005. Furthermore, we imported Pfam 18.0 [35] released
in July 2005 and the SMART domains [44] from the Inter-
Pro release 11.0 [29]. The Gene Ontology [10] term defi-
nitions were taken from the monthly release from August
2005. The protein information and annotations were
imported from UniProt [12] release 5.8 from August
2005. We implemented a program, GOTaxExplorer, to
easily execute the queries and to allow searches involving
all integrated sources. The program is freely available over
the internet at http://gotax.bioinf.mpi-inf.mpg.de.
GO term probability
The probability of a term to occur is assumed to be equal
to its frequency in the annotations in a database [16]. The
frequency of a term is given by
anno(c)+ is the number of gene products annotated with
this term in the database. children(c) is the set of child
nodes of term c. The probability of term t is then defined
as p(c) = freq(c)/freq(root), where freq(root) is the frequency
of the root term. The probability is calculated independ-
ently for each ontology. It is monotonically increasing as
one moves up on a path from a leaf to the root.
Resnik's measure
Resnik uses the concept of "information content" (IC) to
define a semantic similarity measure. The information
content is based on the probability p(c) of a term and
measures the amount of information. The probability
assigned to a term is defined as its relative frequency of
occurrence. The root has probability p(root) = 1 if it is
unique. Resnik uses the negative logarithm to the base 10
of the term's probability, IC(c) = -log10 p(c), as informa-
tion content. The more information two terms share the
higher is their similarity. The shared information is cap-
tured by the set of common ancestors in the graph. The
amount of shared information and thus the similarity
between the two terms is quantified by the information
content of the common ancestors. This leads to the fol-
lowing formula for semantic similarity between two terms
in an ontology:
where S(c1, c2) is the set of common ancestors of terms c1
and c2. The lowest common ancestor (LCA) is the
. The minimum similarity is
zero and there is no maximum for this measure.
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Lin defines the similarity between two terms as the ratio
of the commonality of the terms and the information
needed to fully describe the two terms. The commonality
of the terms is again captured by their common ancestors.
The information needed to fully describe both terms is the
sum of their information, since the random selection of
one term is independent of the random selection of the
second term. This defining equation is given by
S(c1, c2) again is the set of common ancestors of terms c1
and c2. In contrast to Resnik's similarity, the values range
between 0 and 1.
Relevance similarity
In order to take relevance information into account, we
combine Lin's and Resnik's similarity measures. The prob-
ability of the LCA reflects its level of detail. Generic terms
do not have a high relevance for the comparison of the
exact function of different gene products. This results in
the definition
Like simLin, simRel is symmetric, i.e. simRel(c1, c2) = simRel(c2,
c1), and also attains values in the interval [0, 1]. Since the
relevance of a term decreases with increasing probability,
the similarity is weighted with 1 - p(c) in the computation
of simRel.
Calculation of funSim
The first step in the comparison of two gene products is
the pairwise comparison of their GO mappings. The map-
pings to the different ontologies (molecular function and
biological process) are examined separately. Considering
two gene products A and B annotated with the sets GOA
and GOB of GO terms with sizes N and M, respectively, a
similarity matrix S is calculated. This matrix contains all
pairwise similarity values of mappings  of gene
product A and mappings  of gene product B.
sij = sim( , ), ∀i ∈ {1,...,N}, ∀j ∈ {1,...,M}  (5)
The matrix may be calculated with any of the similarity
measures mentioned above (simResnik, simLin, and simRel).
The matrix S is not necessarily symmetric or square since
the proteins can have different types and numbers of GO
mappings. The rows and the columns of S represent two
different directional comparisons, row vectors correspond
to a comparison of A to B and column vectors of B to A.
The best hits for the comparison of A with B are deter-
mined as maximum values in the rows in matrix S (row
maxima). The maximum values in the columns of S (col-
umn maxima) are the best hits for the direction B to A.
The averages over the row maxima and the column
maxima give similarity values for the comparison of A to
B and the comparison of B to A, respectively:
rowScore and columnScore lie in the interval [0, 1].
One alternative of combining the scores for both direc-
tions is to calculate their average. This scoring enforces
that both gene products have the same types of function-
ality because a high score can only be achieved if column-
Score and rowScore are high.
Another alternative is to compute the maximum of rowS-
core and columnScore:
GOscore = max{columnScore, rowScore},  (8)
where GOscore is the generic name for either MFscore if it
is based on molecular function or BPscore if it is based on
biological process. This score does not penalize situations
where all GO terms of one gene product match a subset of
the GO terms of the second gene product. This situation
occurs when the annotation of the first gene product is not
complete or when the second gene product is multi-func-
tional.
funSim
The funSim score is calculated from the MFscore and the
BPscore of a pair of gene products. Two gene products with
a high score in one ontology but only an average score in
the other one can be considered average matches. How-
ever, their score should be higher than the score of two
gene products that are average matches in both categories.
Simply adding MFscore and BPscore or taking the average
would not distinguish between these two cases. Squaring
the MFscore and the BPscore favors high similarity in one
ontology and a low score in the other one over average
scores in both ontologies, thus allowing a distinction
between these two scenarios. Therefore, the funSim score
for two gene products is calculated as:
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mum possible score for biological process and molecular
function, respectively. If simRel is used, the funSim score lies
in the interval [0, 1]. We use simRel for our analysis
throughout the article.
Lin's similarity is not a metric since it does not satisfy the
triangle inequality. This also holds for funSim. funSim can
be applied to any type of gene product that is annotated
with GO terms. Furthermore, it can be calculated with any
semantic similarity measure that has a well-defined maxi-
mum.
Derivation of the set IO
The set with Inparanoid orthologs (IO) was extracted
from Inparanoid version 4.0 [34]. Saccharomyces cerevisiae
proteins and human proteins with a score of 1.0 have
been extracted from each Inparanoid cluster. All yeast-
human protein pairs where both proteins had biological
process and molecular function annotation were used. In
total 682 protein pairs were obtained.
Derivation of the sets LSS and HSS
For the two sets of protein pairs with low sequence simi-
larity (LSS) and high sequence similarity (HSS), a BLAST
[45,46] search of all yeast proteins from the IO set against
all human proteins from Inparanoid was performed. All
human sequences without biological process or molecu-
lar function annotation were filtered out. The proteins
where mapped to UniProt using the ENSEMBL [47]
BioMart tool on October 26th, 2005. All sequences with-
out GO annotation were excluded. We mapped the SGD
accession numbers of the yeast protein sequences to Uni-
Prot accession numbers with the UniProt 5.8 dat files. A
BLAST comparison was carried out with version 2.2.12.
Default parameters with an e-value threshold of 0.003
were used. The LSS data set contains for each yeast protein
the human protein with the highest e-value that is not the
ortholog. The human protein with the lowest e-value that
is not the ortholog was included in the HSS dataset. Each
of the two sets contains 989 protein pairs.
Derivation of the set NSS
In order to compile a set of protein pairs with no sequence
similarity (NSS), all human proteins with biological proc-
ess and molecular function annotation that are not in the
IO set were selected. One of these human proteins was
assigned randomly to each yeast protein from the IO set.
The proteins had no significant sequence similarity. The
NSS set contains 1356 protein pairs.
Comparison with Lord et al
We used the IO, HSS, LSS, and NSS datasets mentioned
before for this analysis. The semantic similarity between
single GO terms was calculated using the simRel measure.
For the comparison of proteins, the GOscoreLord was com-
puted according to the following formula:
This corresponds to the original definition form Lord et al.
[16]. MFscoreLord and BPscoreLord correspond to the GOscore-
Lord for molecular function and biological process, respec-
tively.
Comparisons
We compared the biological processes from fungi to proc-
esses from mammals and the comparison of molecular
functions from Mycobacteria to functions from mammals.
The distributions for IO, HSS, LSS, and NSS where calcu-
lated using the funSim score. The MFscore and the BPscore
were used to calculate the corresponding GO score distri-
butions for the IO set. The comparison of yeast with
human proteins was done with the funSim score. In this
comparison, we used the 7356 yeast proteins and the 70
447 proteins from human from UniProt release 5.8.
Almost 3 000 proteins could not be analyzed because
there is no GO annotation available. Another 1 300 pro-
teins have either no molecular function or no biological
process assigned, giving an incomplete score. The data
files for the comparison of biological processes from fungi
and mammals ("bp_fungi_mammals.txt"), the compari-
son of molecular functions from Mycobacteria and mam-
mals ("mf_myco_mammals.txt"), and the funSim
comparison of yeast with human ("sc_hs.txt") are availa-
ble for download at http://gotax.bioinf.mpi-inf.mpg.de/
raw_data/.
Multidimensional scaling
The statistical software environment R (http://www.r-
project.org) was used to perform metric multidimen-
sional scaling (MDS). All yeast proteins with molecular
function annotation were compared mutually yielding a
square symmetric similarity matrix. Since the MFscore is a
similarity measure and no distance, the distance of two
proteins was computed as dmf = 1 - MFscore. The same pro-
cedure was applied to the molecular function annotation
of the Pfam families. A square symmetric dmf matrix was
used as input for the cmdscale method in R to perform a
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dimensional space and dij the respective distance in the
original space. The change rate of normalized stress (CR)
was calculated as
with k being the number of dimensions. Densities have
been estimated with a two-dimensional Gaussian kernel
estimation by the kde2d function from the R software.
Hierarchical clustering
The hierarchical clustering was done with Pycluster ver-
sion 1.29 (http://bonsai.ims.u-tokyo.ac.jp/~mdehoon/
software/cluster/software.htm) and Python 2.4.2 (http://
www.python.org) using a maximum linkage clustering
algorithm. The distance matrix was the same as used for
the MDS.
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